Partial-onset Seizures
📧 Sign up to get email alerts when something new happens for Partial-onset Seizures.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-03FDA Approved: ESLICARBAZEPINE ACETATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' eslicarbazepine acetate as a generic, original-application product for adjunctive treatment of partial-…
-
FDA approval · 2023-07-21FDA Approved: PREGABALIN — Supplemental Application (Eskayef Pharmaceuticals Limited)
FDA approved a supplemental application for pregabalin (generic) submitted by Eskayef Pharmaceuticals Limited.
-
FDA approval · 2023-07-21FDA Approved: LACOSAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for lacosamide from ANI Pharmaceuticals, Inc., under ANDA 216151.
-
FDA approval · 2023-07-13FDA Approved: OXCARBAZEPINE — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s generic oxcarbazepine under an Original Application (ANDA 213369). This approval makes the generic oxcarbaze…
-
FDA approval · 2023-07-12FDA Approved: LACOSAMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for lacosamide, a generic antiseizure medication used as adjunctive therapy fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-07-12FDA Approved: PREGABALIN — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals Limited's original application for pregabalin, enabling a generic version of the drug.
-
FDA approval · 2023-06-26FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for pregabalin under ANDA 207623, indicating approval of changes to this gene…
-
FDA approval · 2023-06-21FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for pregabalin from Ascend Laboratories, LLC (ANDA207799), indicating approval of a supplemental fil…
-
FDA approval · 2023-06-13FDA Approved: LEVETIRACETAM — Original Application (Granules Pharmaceuticals Inc.)
FDA approved a generic version of levetiracetam from Granules Pharmaceuticals Inc. under an original ANDA (ANDA217878), expanding access to …
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a generic pregabalin from Rising Pharma Holdings, Inc., authorizing its marketing for the same i…
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin from Alembic Pharmaceuticals Inc., enabling a generic version to be marketed.
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for pregabalin from Dr. Reddy's Laboratories Inc., authorizing a generic version under the approved …
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN CAPSULES, CV — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for Pregabalin Capsules, CV, enabling the marketing of a generic pregabalin capsule p…
-
FDA approval · 2023-05-17FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc., marking an approved modification to the exis…
-
FDA approval · 2023-04-28FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for VIMPAT (lacosamide) submitted by UCB, Inc., finalizing the regulatory action on the product.
-
FDA approval · 2023-03-31FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)
The FDA approved a supplemental application from ScieGen Pharmaceuticals, Inc. for a generic pregabalin product. The approval covers the sam…
-
FDA approval · 2023-03-28FDA Approved: LACOSAMIDE ORAL SOLUTION — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application to authorize lacosamide oral solution from Ascend Laboratories, expanding the product's dosage f…
-
FDA approval · 2023-03-24FDA Approved: PREGABALIN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for pregabalin from Solco Healthcare US, LLC under ANDA207883. The drug is indicated for neuropathic…
-
FDA approval · 2023-03-24FDA Approved: PREGABALIN — Supplemental Application (Tris Pharma Inc)
FDA approved a supplemental application for pregabalin submitted by Tris Pharma Inc.
-
FDA approval · 2023-03-14FDA Approved: OXCARBAZEPINE — Supplemental Application (EPIC PHARMA, LLC)
The FDA approved a supplemental application for oxcarbazepine filed by Epic Pharma, LLC.
-
FDA approval · 2023-02-09FDA Approved: LACOSAMIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original generic application for lacosamide by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2023-02-06FDA Approved: LACOSAMIDE — Original Application (Kanchan Healthcare Inc)
FDA approved a generic lacosamide product under ANDA216461, produced by Kanchan Healthcare Inc. This adds a generic option for lacosamide in…
-
FDA approval · 2023-01-18FDA Approved: LACOSAMIDE — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for lacosamide submitted by XLCare Pharmaceuticals Inc., updating the product labeling under the…
-
FDA approval · 2023-01-06FDA Approved: BRIVARACETAM — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of brivaracetam from Aurobindo Pharma Limited under an Original Application (ANDA 214848).
-
FDA approval · 2023-01-05FDA Approved: LACOSAMIDE — Original Application (Aurobindo Pharma Limited)
FDA granted approval for lacosamide as an Original Application for Aurobindo Pharma Limited, enabling a generic lacosamide product.